Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin.
about
Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection modeLocalization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies.Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitopeInduction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles.CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus.Transcription of woodchuck hepatitis virus in the chronically infected liver.In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenoviruses.Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primatesHepatitis B virus: where do we stand and what is the next step for eradication?DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans.Boosting immune response to hepatitis B DNA vaccine by coadministration of Prothymosin alpha-expressing plasmid.Serological responses to HBV infection.Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domainNonoverlapping T and B cell determinants on an hepatitis B surface antigen pre-S(2) region synthetic peptide.Immunotherapeutic relief from persistent infections and amyloid disorders.Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge.Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptorDistinctive properties of the hepatitis B virus envelope proteins.Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 regionExpression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic miceRegulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein.Selective synthesis and secretion of particles composed of the hepatitis B virus middle surface protein directed by a recombinant vaccinia virus: induction of antibodies to pre-S and S epitopes.In vitro recombinants of ground squirrel and woodchuck hepatitis viral DNAs produce infectious virus in squirrelsAssembly of viral particles in Xenopus oocytes: pre-surface-antigens regulate secretion of the hepatitis B viral surface envelope particle.DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines.Expression in Escherichia coli of a cloned DNA sequence encoding the pre-S2 region of hepatitis B virus.Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S regionVirus-like particles in vaccine development.Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.Towards a recombinant vaccine against diphtheria toxinExpression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences.Expression of hepatitis B virus middle and large surface antigen genes in Saccharomyces cerevisiae.[Vaccination against hepatitis B: success and challenges].Immunogenicity of hybrid hepatitis B surface antigen particles.Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein.Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytesHepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.Expression of the human hepatitis B virus large surface antigen gene in transgenic tomato plants.
P2860
Q27480864-5599A219-A816-4BE1-9915-D02C05919E99Q30708343-2F95F016-2D21-4071-BDE5-BAC466D42A22Q33557944-5158752F-BAC4-4FCD-9E17-84E996DCAE9CQ33660809-873BB047-5704-49A4-B965-1941C27C0D81Q33843264-D610E756-EFD2-49C1-B9DA-D2AB819DB778Q33926692-97FADBF0-FB06-4FAC-A304-499D7153D4B2Q33931416-5ABE69C4-59EB-4166-8F58-7A1214B54AFDQ33932227-430104D4-EA0A-450E-ACCF-9600D90CE306Q33933855-EA5BDBB9-20B2-4196-A802-0A9B12F356E8Q33958764-5040F294-E0C7-445B-B4A1-78D5F13147F0Q34209003-C6E22C83-786E-4F11-A6F3-A75D941C7911Q34231216-F1274C3A-4E53-4BD3-B0DE-F80FC659A45FQ34529889-F22EC703-ED33-4FB1-837C-43D986365616Q35831642-07DDFFE1-9ED2-423C-949A-75CF30C5A480Q36352272-50CCA58B-39F9-4906-8FA0-01628C2167C4Q36375893-35D19661-36F7-42B6-A955-1EBE9B1FA88CQ36636293-AF61B9C8-F7E4-48F6-8620-9DF5034B22BFQ36650363-8CF5F463-9B3C-492D-B227-B26889FFB930Q36826782-FBC62B5D-BA42-48F2-98A8-D4A9976D878EQ36827256-504D8B00-F50F-41EF-876A-9E0A7F1631D7Q36869563-255524B1-680C-44EF-997D-2A4C3EA29BEAQ36885512-645C5732-0274-410A-A72A-4BFAF6BF7B34Q36886949-03AD978A-123B-47C4-BB02-636A24258606Q36919330-76A76575-7ACC-43C7-A877-B70E544D47D6Q37410774-E7523B01-BA52-41B8-A9B6-DB2B893C8C63Q37495259-91BAC3A9-E091-405A-992B-32ADE36C7470Q37536929-115BE967-C735-4F7C-8CDD-89A488BA81A9Q37557540-2671F740-71BE-420F-814C-3DB14C1FD1A7Q37798008-26B8C524-3A97-480D-942B-E5C5CEECA5C0Q38293584-98D7FE76-B67C-4386-87B0-CABC072500C9Q39025466-6203F995-4046-4F88-954E-81D7FE2005F6Q39569810-A6FC06E8-0255-4E80-B692-FB969CAA37F5Q40131681-D5FF3D89-C7F1-4ADC-8008-5B5CDDC1665DQ40141149-7B3D5AE6-4E62-4B23-A6E9-98448250AB2CQ40544414-BF7FA75A-EE6E-4695-8111-4E2BA645A8A1Q40680970-C5F37FB0-434D-45C8-8773-36FCED6D90A7Q41640826-00C6EB80-E297-41BD-946D-3C92B72D7744Q41887540-A67B5915-4853-4DC6-B049-50230E71101AQ42251440-EFE10AD2-B07F-4CA7-864B-3D9CCB3B5A7BQ42800873-CFD89EB9-1A60-41A9-A33D-FB96C4768253
P2860
Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1984
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synthesis in animal cells of h ...... lymerized human serum albumin.
@en
Synthesis in animal cells of h ...... lymerized human serum albumin.
@nl
type
label
Synthesis in animal cells of h ...... lymerized human serum albumin.
@en
Synthesis in animal cells of h ...... lymerized human serum albumin.
@nl
prefLabel
Synthesis in animal cells of h ...... lymerized human serum albumin.
@en
Synthesis in animal cells of h ...... lymerized human serum albumin.
@nl
P2093
P2860
P356
P1476
Synthesis in animal cells of h ...... lymerized human serum albumin.
@en
P2093
P2860
P304
P356
10.1073/PNAS.81.24.7708
P407
P577
1984-12-01T00:00:00Z